ConvaTec Group PLC Value Stock - Dividend - Research Selection
Market price: 2,75 USD
ConvaTec Group PLC Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||401.800.000|
|Free cash flow||340.400.000|
|Liabilities & Shareholders equity||3.609.800.000|
|Diluted shares outstanding||1.970.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||5.476.599.808,00 USD|
|Raw Data Source||IFRS in Millionen USD|
Description of the company
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes. The company also provides a portfolio of wound dressings that include antimicrobial and foam dressings to manage chronic wounds comprising pressure, venous leg, and diabetic foot ulcers. In addition, it offers devices, accessories, and services consisting of Esteem+ one-piece and Natura+ two-piece advanced pouch ranges for people with an ostomy or stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. Further, the company provides continence and critical care products, including intermittent urinary catheters; advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and a range of disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, and gastroenterology tubes. Additionally, it offers disposable infusion sets to the suppliers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and a range of products to hospitals and the home healthcare sector. The company markets its products through internal sales force, distributors, wholesalers, hospitals, specialist medical stores, pharmacies, and homecare agencies. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 2008 and is headquartered in Reading, the United Kingdom.